Compare Uranium Energy Corp (UEC) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Uranium Energy Corp vs Zimmer Biomet Holdings Inc — how do they compare? Uranium Energy Corp trades at $11.46 (market cap $5.67B), while Zimmer Biomet Holdings Inc trades at $96.49 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 3.3× Uranium Energy Corp's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.
| UEC | ZBH | |
|---|---|---|
Market Cap | $5.67B | $18.55B |
Sector | Energy | Health |
52-Week High | $20.14 | $107.71 |
52-Week Low | $9.04 | $79.58 |
Enterprise Value | $5.18B | $25.61B |
Dividend Yield | — | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Uranium Energy Corp (UEC) trades at $11.45, up 0.62% today, with a bullish technical signal supported by moving averages. The company shows significant financial challenges with a net income margin of -513.24% and negative cash flow from operations, though it maintains strong analyst support with 87.5% buy ratings. Recent news highlights insider selling but also optimistic long-term nuclear energy prospects.
UEC presents high-risk, high-reward potential driven by nuclear energy tailwinds, but faces substantial execution risks amid persistent losses and premium valuation. The stock's outlook hinges on production ramp-up success and uranium price movements, with current financials indicating cautious near-term investor sentiment despite bullish analyst consensus.
ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.
The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
